据统计，线下双选会共吸引345家企事业单位招贤引才，提供就业岗位逾7000个，现场入场求职超4000 人次，线上线下共投递简历达16560份，初步达成就业意向6316人次，现场签约293人。 东莞市腾信精密制造股份有限公司行政部经理张春华称，近年来，技工院校人才培养更加贴近行业需 求，尤其能够提供模块化课程、校企联合实训平台，培养的学生不仅掌握专业理论基础，更具备项目实 践与动手能力，这对企业来说是非常契合的。 目前，广东共有技工院校148所，其中63所技工院校开设工业机器人相关专业，17所技工院校开设人工 智能相关专业。 数据显示，本次双选会"线上+线下"联动来自人工智能、工业机器人、智能制造、现代服务等领域的600 余家企业参与招聘，为技能人才提供"全天候""跨地域""多场景"的择业通道。 来源：中国新闻网 中新网东莞5月8日电 (记者 程景伟)广东省人工智能与机器人产业技能人才培养交流会暨技能人才双选 会近日在东莞启动。本次双选会采用"1天线下+2周线上"融合模式，线上线下联动、岗位招聘与职业指 导并举，搭建起技术技能人才与高质量岗位精准匹配的多维平台。 签约仪式 现场。广东省人社厅 供图 会上发布了广 ...

NVE (NVEC) Q4 2025 Earnings Call May 07, 2025 05:00 PM ET Company Participants Daniel A. Baker - Director, President & CEODaniel Nelson - Controller & Principal Financial OfficerJeffrey Bernstein - Partner Daniel A. Baker Good afternoon, and welcome to the NVE Corporation conference call for the quarter and fiscal year ended 03/31/2025. I'm Dan Baker, NVE's President and CEO. I'm joined as usual by Controller and Principal Financial Officer, Daniel Nelson. This call is being webcast live via YouTube and Ama ...

Digi International (DGII) Q2 2025 Earnings Call May 07, 2025 05:00 PM ET Company Participants Jamie Loch - EVP, CFO & TreasurerRon Konezny - President, Chief Executive OfficerTommy Moll - Managing Director Conference Call Participants None - AnalystScott Searle - Managing Director, Senior Research Analyst Operator Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker, Chief Financial Officer, Jamie Locke. Please go ahead. Jamie Loch Thank y ...

Digi International (DGII) Q2 2025 Earnings Call May 07, 2025 05:00 PM ET Speaker0 Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker, Chief Financial Officer, Jamie Locke. Please go ahead. Speaker1 Thank you. Good day, everyone. It's great to talk to you again, and thanks for joining us today to discuss the earnings results of Digi International. Joining me on today's call is Ron Konezny, our President and CEO. We issued our earnings rel ...

Core Insights - Markel Insurance has launched a Clinical Trials insurance product to support clinical trials research and product development globally [1][5] - The new offering provides comprehensive coverage for sponsors, researchers, and participants across all phases of clinical research, tailored to meet regulatory requirements in over 100 territories [1][2] Group 1: Product Features - The Clinical Trials insurance product ensures timely issuance of quotations and policy documents through an automated platform, facilitating compliance with regulatory deadlines [2] - Markel's solution is designed to prevent delays in the clinical research process, which can lead to significant costs and reputational damage [3][4] Group 2: Industry Commitment - Markel aims to support innovation in the life sciences sector by providing effective risk transfer solutions for future lifesaving treatments [5] - The company emphasizes a people-first approach, leveraging relationships with brokers and clients to differentiate itself in the specialty insurance market [5]

Supernus Pharmaceuticals (SUPN) Q1 2025 Earnings Call May 06, 2025 04:30 PM ET Company Participants Peter Vozzo - Managing DirectorJack Khattar - CEO, President & DirectorTimothy Dec - Senior VP & CFOJack Padovano - Equity Research Associate - BioPharma Conference Call Participants None - AnalystStacy Ku - AnalystDavid Amsellem - Sr. Research Analyst Operator Good afternoon, and welcome to Supernus Pharmaceuticals First Quarter twenty twenty five Financial Results Conference Call. At this time, all particip ...

The Williams Companies (WMB) Q1 2025 Earnings Call May 06, 2025 09:30 AM ET Company Participants Danilo Juvane - Vice President, Investor RelationsAlan Armstrong - President & CEOJohn Porter - Senior VP & CFOChad Zamarin - Executive Vice President of Corporate Strategic DevelopmentLarry Larsen - EVP & COOGabriel Moreen - Managing DirectorJean Ann Salisbury - Managing DirectorT. Lane Wilson - SVP & General CounselManav Gupta - Executive DirectorZack Van Everen - Director - Equity ResearchKeith Stanley - Dire ...

Core Viewpoint - The company is actively engaging in research and development, focusing on integrating advanced technologies such as DeepSeek into its products, while also navigating challenges such as rising costs and international trade issues. Group 1: Financial Performance - In Q1 2025, the company reported a main revenue of 80.79 million yuan, an increase of 7.01% year-on-year, while the net profit attributable to shareholders decreased by 48.44% to 7.97 million yuan [7] - The company's gross profit margin stands at 60.18%, with a debt ratio of 15.37% [7] Group 2: Cost Management - The increase in expenses for 2024 is attributed to enhanced R&D, sales team development, and market expansion, leading to higher personnel costs, business entertainment, and travel expenses [2] - The company has implemented a comprehensive budget management mechanism to align resources with strategic goals and performance targets [2] Group 3: Technological Integration - The company has successfully integrated its edge gateway with the DeepSeek model, enabling real-time semantic understanding and inference of heterogeneous data [3] - This integration allows for automatic identification of equipment anomalies and enhances operational efficiency in industrial scenarios [3] Group 4: Industry Outlook - The coal mining industry is expected to see stable growth, driven by national policies aimed at achieving full automation and smart systems by 2035 [4] - The company anticipates significant opportunities in the coal mining sector as the government pushes for intelligent mining solutions [4] Group 5: International Trade Impact - The company assesses that the impact of the US-China tariff situation is manageable, as overseas revenue is not significantly high, and strategic reserves for chips have been established [5] - Potential indirect effects on clients due to tariffs are acknowledged, but overall, the impact is considered controllable [5] Group 6: Market Expansion - The company plans to strengthen its presence in emerging markets like Southeast Asia and the Middle East while also increasing efforts in mature markets such as Europe and the US [6] - Localized sales and service teams will be established to better understand and meet local market demands [6]

May 5, 2025 09:01 PM GMT China Emerging Frontiers Frontier 28: Investing in Evolving Trends We continue our China Emerging Frontiers series with the introduction of our six-factor framework to understand the successful ingredients underpinning the industrial upgrade story and identify future investment opportunities. Key Takeaways Investors interested in exploring new emerging sectors where China is poised to have structural competitive advantages should consider reading this report. This report outlines ho ...

- Implementation of cost reduction initiatives to position Pliant for execution of late-stage clinical trials - Pliant will reduce its current workforce by approximately 45% - Closing activities for BEACON-IPF trial ongoing; topline data expected in the second quarter of 2025 SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced a strategic restructuring of its workforce and other cost saving actions to extend the cash runway to support execut ...